4626 - 4650 of 9145 Results
Title
Year
-
OPENTitle: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 724End Page: 735Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133481Citation Count: 126
-
OPENTitle: Evaluating the Role of α‐Synuclein Seed Amplification as a Disease Progression Marker: Evidence and UncertaintiesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 13Issue #: 5Start Page: 1228End Page: 1235Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.70434Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.70434Citation Count: 0
- Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-Branch2020OPENTitle: Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-BranchJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 6Start Page: 1442End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9061442Best OA location URL: https://www.mdpi.com/2073-4409/9/6/1442/pdf?version=1592474637Citation Count: 22
- Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease2019RESTRICTEDTitle: Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 126Issue #: 6Start Page: 789End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-019-02015-xCitation Count: 3
-
OPENTitle: Aging and metabolism contribute separately to brain–body healthJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 24Issue #: 6Start Page: e3003856End Page: e3003856Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3003856Best OA location URL: https://www.ukbiobank.ac.uk/media/0xsbmfmw/egf.pdfCitation Count: 0
-
OPENTitle: CLIPPERS: A Treatable Cause of Spastic AtaxiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 212End Page: 214Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12602Citation Count: 2
-
OPENTitle: Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contactsJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 113Issue #: 30Start Page: E4357End Page: 66Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1523708113Best OA location URL: https://www.pnas.org/content/pnas/113/30/E4357.full.pdfCitation Count: 155
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 7Start Page: 1253End Page: 1263Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://doi.org/10.1177/1877718x251356503Citation Count: 2
-
OPENTitle: An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 alleleJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 127Issue #:Start Page: 278End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2019.02.023Best OA location URL: https://doaj.org/article/6a674f9f412742f7840d1c3d8f970659Citation Count: 35
-
OPENTitle: Importance of the Brain Angiotensin System in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/860923Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/860923.pdfCitation Count: 29
- Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease2023OPENTitle: Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 899End Page: 903Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29342Best OA location URL: https://doi.org/10.1002/mds.29342Citation Count: 20
- Vocal tics in Tourette's syndrome2016RESTRICTEDTitle: Vocal tics in Tourette's syndromeJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 15Issue #: 3Start Page: e1End Page: e1Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)00021-1Citation Count: 5
-
OPENTitle: Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease PatientsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page: 38End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00038Best OA location URL: https://doi.org/10.3389/fnagi.2017.00038Citation Count: 65
-
OPENTitle: Sorting (Nexin-13) out Novel Insights into Endolysosomal Cholesterol ExportJournal Name: ContactPublisher: SAGE PublicationsVol: 5Issue #:Start Page: 251525642211145End Page: 251525642211145Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/25152564221114513Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/25152564221114513Citation Count: 2
- Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease2019OPENTitle: Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 402Issue #:Start Page: 81End Page: 85Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.009Best OA location URL: https://zenodo.org/record/3873416Citation Count: 6
-
OPENTitle: A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/364684Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/364684.pdfCitation Count: 17
- Thalamic deep brain stimulation for drug-induced tremor2015RESTRICTEDTitle: Thalamic deep brain stimulation for drug-induced tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 11Start Page: 1369End Page: 1370Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.033Citation Count: 7
-
OPENTitle: Transdifferentiation of Mouse Embryonic Fibroblasts into Dopaminergic Neurons Reactivates LINE-1 Repetitive ElementsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 60End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.002Best OA location URL: http://www.cell.com/article/S2213671119304163/pdfCitation Count: 26
-
OPENTitle: Replication and reliability of Parkinson's disease clinical subtypesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 124Issue #:Start Page: 107016End Page: 107016Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107016Best OA location URL: http://www.prd-journal.com/article/S1353802024010289/pdfCitation Count: 2
-
OPENTitle: Association of mitochondrial genomic background with risk of Multiple System AtrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 200End Page: 204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.040Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7769955Citation Count: 7
-
OPENTitle: Targeted deletion ofGD3synthase protects againstMPTP‐induced neurodegenerationJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 16Issue #: 5Start Page: 522End Page: 536Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1111/gbb.12377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/gbb.12377Citation Count: 22
- Deep brain stimulation of the substantia nigra for freezing of gait in Parkinson's disease: is it about stimulation frequency?2018RESTRICTEDTitle: Deep brain stimulation of the substantia nigra for freezing of gait in Parkinson's disease: is it about stimulation frequency?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 229End Page: 230Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.010Citation Count: 17
- Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease2021RESTRICTEDTitle: Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.010Citation Count: 11
-
OPENTitle: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonismJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 395Issue #:Start Page: 115474End Page: 115474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474Best OA location URL: https://doi.org/10.1016/j.expneurol.2025.115474Citation Count: 0
-
OPENTitle: Tetrabenazine‐induced acute dystonic reaction during the treatment of comorbid tics in a young woman with autism spectrum disorderJournal Name: Psychiatry and Clinical NeurosciencesPublisher: WileyVol: 78Issue #: 9Start Page: 558End Page: 559Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/pcn.13705Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/pcn.13705Citation Count: 1